Company intelligence

TLSI

TriSalus Life Sciences, Inc. · NASDAQ · Healthcare

Price$4.39+1.15% · +$0.05

Market cap270.31MEquity value

P / E-2.6Trailing ratio

Volume253.77KLatest session

Market data

TLSI price chart

TradingView

Related signals

1 min delayed

Browse public TLSI signals with their source context and measured market impact. Open any signal for its permanent analysis page.

TLSISep 23, 2026-12.52% since signal

TriSalus Wins FDA Clearance; TLSI Poised for Near-Term Upside

TriSalus Life Sciences surged 5.8% to $5.22 after announcing FDA 510(k) clearance for TriNav Advance, a regulatory milestone for its device portfolio. The move suggests near-term upside from potential TriNav adoption, though outcome depends on clinical uptake and future catalysts. The session overall was mixed, with the Nasdaq down more than 100 points, signaling a cautious market backdrop.

View signal analysis

TLSISep 22, 2026+1.42% since signal

FDA clearance for TriNav Advance expands TLSI PEDD portfolio

TriSalus Life Sciences announced FDA 510(k) clearance for TriNav Advance, the latest addition to its PEDD portfolio. The milestone adds regulatory validation to TLSI's delivery technology and could broaden the addressable solid-tumor market. While the impact on near-term revenue remains uncertain, the event creates a new commercialization catalyst and potential partnerships, contingent on adoption and reimbursement dynamics.

View signal analysis

Research